
By Kapitall : Wish you could get an inside peak at your favorite companies? One idea is to consider insider stock buying trends. With this idea in mind, we ran a screen. We began by screening the healthcare sector for stocks that have outperformed the market over the last quarter, with at least a
Now that EnteroMedics ETRM has made significant progress on ..... Australia. For the first time, EnteroMedics booked product revenue, following ..... distributor. Perhaps most important, EnteroMedics has put financing in place to keep
It may take more trial and error for EnteroMedics to hone in on efficacious prescriptive ..... Maestro.For the first half of 2010, EnteroMedics fell short of meeting Nasdaq listing ..... could fall below that threshold again. EnteroMedics ' key patent that covers electrical
EnteroMedics ( ETRM -9.1% ) is down after closing out its secondary offering of 8.8M common shares and 1.76M warrants. It will use the proceeds
EnteroMedics ETRM saw its shares run up substantially ..... outcome has breathed some hope into EnteroMedics ' stock. However, this is not enough ..... to raise our fair value estimate for EnteroMedics at this time. Nonetheless, we are
EnteroMedics ETRM shared favorable data on its obesity ..... fourth quarter, which is when we expect EnteroMedics will run out of cash. We're not ..... what happened several years ago, when EnteroMedics reported impressive weight loss results
We're placing EnteroMedics ETRM under review as the company continues to burn through its available ..... holds steady, it should run out of funds in the fourth quarter. EnteroMedics is in a catch-22 situation: it must raise funds in order to
As EnteroMedics ETRM has shared more details on further ..... not be surprised if the agency asks EnteroMedics to conduct a new randomized controlled ..... pump another $4.8 million into EnteroMedics to fund further development of Maestro
Volkswagen AG ADR VLKAY -22.39 -35.27 -69.29 Capital Trust, Inc. A CT -12.31 -65.35 -68.33 EnteroMedics , Inc. ETRM -20.34 -90.41 -67.81 Jackson Hewitt Tax Service, Inc. JTX 37.59 23.59 -63.61 YRC Worldwide
very disappointing look at the preliminary data from EnteroMedics ' ETRM pivotal Empower trial in September, the company ..... makers. If it pursues another large-scale trial, EnteroMedics will again be seeking more cash.